Rare diseases
Investigational molecules
Locations
Back to Austria2 clinical trials in Mödling, Austria. Every trial is listed in the EU Clinical Trials Register and updated daily.
AustriaAustriaThe busiest research cities in the country
What the registry says about research in the country
Clinical research focusing on Type 2 Diabetes Mellitus patients, exploring innovative approaches to prevent heart disease. The trials evaluate the effectiveness of intensive treatment using RAS-antagonists and beta-blockers compared to standard therapy.
Studies utilize specialized biomarkers like NT-proBNP to guide treatment strategies and reduce hospitalization rates.
Investigating advanced treatments for ischemic stroke prevention, with particular focus on patients who have experienced acute non-cardioembolic strokes or high-risk transient ischemic attacks.
The research evaluates the efficacy of asundexian, an oral FXIa inhibitor, in combination with standard antiplatelet therapy.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
